Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Aandeel Biophytis PSE:ALBPS.FR, FR001400OLP5

Laatste koers (eur) Verschil Volume
0,659   +0,101   (+18,10%) Dagrange 0,567 - 0,688 182.272  

Biophytis in 2020. Raket of stille dood?

258 Posts
Pagina: «« 1 ... 8 9 10 11 12 13 | Laatste | Omlaag ↓
  1. forum rang 5 Louis7 20 april 2022 15:53
    April 19 (Reuters) - Biophytis SA :

    BIOPHYTIS PRESENTS SARCONEOS (BIO101) DEVELOPMENT PROGRAM IN SARCOPENIA AT 12TH ANNUAL INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH (ICFSR) IN BOSTON APRIL 20-22, 2022.

    FOLLOWING FIRST MEETING WITH FDA IN JANUARY 2022, A SECOND MEETING IS PLANNED IN Q3 2022 TO DISCUSS SARA DEVELOPMENT PLAN INCLUDING PHASE 2-3 PROTOCOL. OBJECTIVE IS TO HAVE A FPI (FIRST PATIENT IN) FOR THIS NEW STUDY AT END OF H2 2022.

    WE ALSO PLAN TO HAVE DISCUSSIONS WITH EMA DURING H2 2022, IN ORDER TO OBTAIN SCIENTIFIC ADVICE ON PHASE 2 RESULTS AND PROGRESSION TOWARD A PHASE 2-3.

    THESE PLANS REMAIN SUBJECT TO REGULATORY AUTHORIZATIONS AND PROCEDURES, ANY DELAYS IN PATIENT RECRUITMENT OR RETENTION, INTERRUPTIONS IN SOURCING OR SUPPLY CHAIN, AND TO COVID-19-RELATED Delays.

    Gdansk.newsroom@thomsonreuters.com;
258 Posts
Pagina: «« 1 ... 8 9 10 11 12 13 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.